Support hotline:
(Mon. - Fri.: 09:00 - 18:00)

Ruling of the Federal Social Court supports reimbursement of MyoPro by the statutory health insurance system

MyoPro patient wins lawsuit against DAK, Germany's third-largest health insurer


BOSTON-(BUSINESS WIRE)-Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that provides increased functionality to people suffering from neurological disorders and upper limb paralysis, today announced that in an appeal before the Berlin-Brandenburg Regional Social Court (L 9 KR 210/21), the court confirmed that the MyoPro electric whole-arm orthosis is an orthopedic device designed to directly compensate for disabilities. Based on this ruling, Germany's third-largest health insurer, DAK, was ordered to cover the costs of the MyoPro for the plaintiff.

"The MyoPro, which uses non-invasive sensors inside the device to detect even weak contractions of muscle fibers, enables functions such as gripping, holding and opening the hand, as well as bending, lifting and extending the elbow."


The complaint was filed by a 33-year-old man who had applied to the DAK for a myoelectric orthosis following a car accident. The MyoPro helps patients who suffer a loss of function of the hand and arm after a stroke or neuromuscular damage, as well as after spinal cord and nerve injuries, to compensate for the restriction and restore the range of motion.

"With this ruling, a court has confirmed that the MyoPro is a device that can help patients with upper extremity impairments and should be covered by public health insurance. We expect that this ruling will make it easier for patients like the plaintiff to obtain a MyoPro," said John Frijters, managing director of Myomo Europe GmbH. "The MyoPro, which uses non-invasive sensors inside the device to detect even weak contractions of muscle fibers, enables functions such as gripping, holding and opening the hand, as well as bending, lifting and extending the elbow."

The patented MyoPro technology was developed by Myomo in collaboration with researchers at the Massachusetts Institute of Technology and Harvard Medical School. The plaintiff in the case, identified as Konrad T., stated, "Since my paralysis, I've been waiting to be able to move and use my hand and arm again." The plaintiff's attorney, Torsten Bornemann of Goßens Rechtsanwälte, added, "We hope that this ruling will now give many affected Germans easier access to this orthopedic device."

About Myomo, Inc.

Myomo, Inc. is a wearable medical robotics company that provides enhanced arm and hand functions for people with neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is an upper limb electrical orthosis that supports the arm and restores function to the weakened or paralyzed arms of patients suffering from stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only device on the market that captures the patient's EMG signals via non-invasive sensors on the arm, which can restore the patient's ability to perform activities of daily living, such as feeding themselves, carrying objects and performing household tasks. Many are able to return to work, live independently and reduce their care costs. Myomo is headquartered in Boston, Massachusetts, and has sales and clinical experts in the U.S. and Germany, as well as other international representatives.

Source: Ruling by German Social Court Supports MyoPro Reimbursement by Nation's Statutory Health Insurance System | Business Wire (07.12.2022)

Tom Illauer

All contributions from: 
en_USEnglish